Compare Healthcare Stocks

Date Range: 

 Johnson & JohnsonMerck & Co., Inc.PfizerNovartisUnitedHealth Group
SymbolNYSE:JNJNYSE:MRKNYSE:PFENYSE:NVSNYSE:UNH
Price Information
Current Price$163.81$71.93$44.20$82.80$412.70
50-Day Moving Average$172.08$76.21$45.13$90.84$416.51
52-Week Low$133.65$70.89$33.36$77.04$289.64
52-Week High$179.92$85.60$51.86$98.52$431.36
MarketRank™
Overall Score2.42.82.72.23.0
Analysis Score2.43.42.13.12.5
Community Score4.44.54.84.35.0
Dividend Score2.53.33.32.52.5
Ownership Score1.71.72.50.02.5
Earnings & Valuation Score1.31.30.61.32.5
Analyst Ratings
Consensus RecommendationBuyBuyHoldHoldBuy
Consensus Price Target$190.38$92.22$43.33$108.50$444.04
% Upside from Price Target16.22% upside28.21% upside-1.96% downside31.04% upside7.59% upside
Trade Information
Market Cap$431.23 billion$182.08 billion$247.82 billion$185.20 billion$389.14 billion
Beta0.710.410.740.540.77
Average Volume7,128,55811,461,91730,980,9981,886,8612,988,197
Sales & Book Value
Annual Revenue$82.58 billion$47.99 billion$41.91 billion$48.66 billion$257.14 billion
Price / Sales5.223.795.913.811.51
Cashflow$10.68 per share$7.24 per share$3.02 per share$8.17 per share$20.66 per share
Price / Cash15.349.9314.6610.1419.98
Book Value$24.04 per share$10.04 per share$11.42 per share$24.76 per share$72.28 per share
Price / Book6.817.163.873.345.71
Profitability
Net Income$14.71 billion$7.07 billion$9.62 billion$8.07 billion$15.40 billion
EPS$8.03$5.94$2.22$5.75$16.88
Trailing P/E Ratio24.6332.8418.9720.9627.26
Forward P/E Ratio15.9011.4512.9612.3819.01
P/E Growth2.232.161.582.071.62
Net Margins19.92%11.48%23.06%17.83%5.33%
Return on Equity (ROE)37.06%50.93%26.49%25.25%22.15%
Return on Assets (ROA)14.04%16.15%10.73%10.74%7.65%
Dividend
Annual Payout$4.24$2.60$1.56$2.08$5.80
Dividend Yield2.59%3.61%3.53%2.51%1.41%
Three-Year Dividend Growth19.88%31.22%-10.94%13.60%68.00%
Payout Ratio52.80%43.77%70.27%36.17%34.36%
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.44%0.72%0.50%0.46%0.62%
Current Ratio1.39%1.31%1.37%0.80%0.77%
Quick Ratio1.13%1.06%1.12%0.56%0.77%
Ownership Information
Institutional Ownership Percentage67.29%71.83%64.93%9.90%86.21%
Insider Ownership Percentage0.30%0.32%0.05%0.01%0.55%
Miscellaneous
Employees134,50074,00078,500105,794330,000
Shares Outstanding2.63 billion2.53 billion5.61 billion2.24 billion942.92 million
Next Earnings Date10/19/2021 (Confirmed)10/28/2021 (Confirmed)10/26/2021 (Estimated)10/26/2021 (Estimated)10/13/2021 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable

Latest Healthcare Stock News

SourceHeadline
UnitedHealth Group Incorporated (NYSE:UNH) Receives Average Rating of "Buy" from AnalystsUnitedHealth Group Incorporated (NYSE:UNH) Receives Average Rating of "Buy" from Analysts
americanbankingnews.com - September 19 at 7:26 AM
Interesting UNH Put And Call Options For November 19thInteresting UNH Put And Call Options For November 19th
nasdaq.com - September 16 at 3:13 PM
Stock Performance Of UnitedHealth Group Incorporated (NYSE: UNH) And OutlookStock Performance Of UnitedHealth Group Incorporated (NYSE: UNH) And Outlook
marketingsentinel.com - September 15 at 6:49 PM
Is UnitedHealth Group Incorporated (NYSE: UNH) Still On Fire This Week?Is UnitedHealth Group Incorporated (NYSE: UNH) Still On Fire This Week?
stocksregister.com - September 15 at 1:49 PM
UnitedHealth Group (UNH) Stock Moves -0.48%: What You Should KnowUnitedHealth Group (UNH) Stock Moves -0.48%: What You Should Know
finance.yahoo.com - September 14 at 10:49 PM
UnitedHealth Group: Patience Is A VirtueUnitedHealth Group: Patience Is A Virtue
seekingalpha.com - September 12 at 12:57 AM
These “Dividend Unicorns” Are Set to Hand You 12% Yields, 970% ProfitsThese “Dividend Unicorns” Are Set to Hand You 12% Yields, 970% Profits
marketbeat.com - September 10 at 10:02 PM
A New Perspective On UnitedHealth Group Incorporated (UNH)A New Perspective On UnitedHealth Group Incorporated (UNH)
stocksregister.com - September 10 at 5:23 PM
Dow Jones Slips As Indexes Reverse Lower; Antitrust Ruling Hits Apple; Economic Data Points To More InflationDow Jones Slips As Indexes Reverse Lower; Antitrust Ruling Hits Apple; Economic Data Points To More Inflation
finance.yahoo.com - September 10 at 5:23 PM
Noteworthy Thursday Option Activity: UNH, CROX, ADSKNoteworthy Thursday Option Activity: UNH, CROX, ADSK
nasdaq.com - September 9 at 5:21 PM
UnitedHealth Group Donates $4.5 Million to Advance Health Equity Among Underserved Communities Across OklahomaUnitedHealth Group Donates $4.5 Million to Advance Health Equity Among Underserved Communities Across Oklahoma
finance.yahoo.com - September 9 at 8:42 AM
Focused Large Cap Value Fund Buys UnitedHealth Group Inc, Allstate Corp, Kimberly-Clark Corp, ...Focused Large Cap Value Fund Buys UnitedHealth Group Inc, Allstate Corp, Kimberly-Clark Corp, ...
gurufocus.com - September 8 at 6:29 AM
NT Focused Large Cap Value Fund Buys UnitedHealth Group Inc, Allstate Corp, Kimberly-Clark ...NT Focused Large Cap Value Fund Buys UnitedHealth Group Inc, Allstate Corp, Kimberly-Clark ...
gurufocus.com - September 8 at 6:29 AM
UnitedHealthcare and Sesame Workshop Celebrate Grandparents Day with New Resources to Help Families Grow in Healthy WaysUnitedHealthcare and Sesame Workshop Celebrate Grandparents Day with New Resources to Help Families Grow in Healthy Ways
finance.yahoo.com - September 7 at 9:06 AM
UnitedHealth Group Incorporated (NYSE:UNH) Looks Interesting, And Its About To Pay A DividendUnitedHealth Group Incorporated (NYSE:UNH) Looks Interesting, And It's About To Pay A Dividend
finance.yahoo.com - September 6 at 7:46 AM
UnitedHealth Group Incorporated (NYSE:UNH) Expected to Announce Earnings of $4.40 Per ShareUnitedHealth Group Incorporated (NYSE:UNH) Expected to Announce Earnings of $4.40 Per Share
americanbankingnews.com - September 5 at 4:40 PM
UnitedHealth Group Incorporated [UNH] Is Currently 1.52 below its 200 Period Moving Avg: What Dose This Mean?UnitedHealth Group Incorporated [UNH] Is Currently 1.52 below its 200 Period Moving Avg: What Dose This Mean?
dbtnews.com - September 3 at 3:55 PM
United Health Foundation Donates $1 Million to Support Residents of Louisiana Affected by Hurricane IdaUnited Health Foundation Donates $1 Million to Support Residents of Louisiana Affected by Hurricane Ida
finance.yahoo.com - September 2 at 6:27 PM
UNH October 22nd Options Begin TradingUNH October 22nd Options Begin Trading
nasdaq.com - September 2 at 6:27 PM
Fast Money Halftime Report Picks For AbbVie, UnitedHealth And More'Fast Money Halftime Report' Picks For AbbVie, UnitedHealth And More
msn.com - September 1 at 9:29 PM
UnitedHealth Group Incorporated (NYSE: UNH) Could Bring Massive Returns?UnitedHealth Group Incorporated (NYSE: UNH) Could Bring Massive Returns?
marketingsentinel.com - September 1 at 4:28 PM
UnitedHealth Group Incorporated (NYSE: UNH)’s Stock Adds 0.32%, Making It A Good InvestmentUnitedHealth Group Incorporated (NYSE: UNH)’s Stock Adds 0.32%, Making It A Good Investment
stocksregister.com - August 31 at 6:04 PM
Morgan Stanley Trims UnitedHealth Group (NYSE:UNH) Target Price to $488.00Morgan Stanley Trims UnitedHealth Group (NYSE:UNH) Target Price to $488.00
americanbankingnews.com - August 31 at 10:14 AM
UnitedHealth Group (NYSE:UNH) Price Target Cut to $488.00 by Analysts at Morgan StanleyUnitedHealth Group (NYSE:UNH) Price Target Cut to $488.00 by Analysts at Morgan Stanley
marketbeat.com - August 31 at 8:14 AM
UnitedHealth Groups (NYSE:UNH) investors will be pleased with their impressive 231% return over the last five yearsUnitedHealth Group's (NYSE:UNH) investors will be pleased with their impressive 231% return over the last five years
finance.yahoo.com - August 30 at 4:47 PM
How to “Front-Run” Share Splits for Fast 40%+ Gains (and Surging Dividends)How to “Front-Run” Share Splits for Fast 40%+ Gains (and Surging Dividends)
marketbeat.com - August 27 at 10:01 PM
Interesting UNH Put And Call Options For October 8thInteresting UNH Put And Call Options For October 8th
nasdaq.com - August 26 at 10:02 PM
Joy Fitzgerald, UnitedHealth Groups Chief Diversity, Equity and Inclusion Officer, Shares Her Passion for a Brighter FutureJoy Fitzgerald, UnitedHealth Group's Chief Diversity, Equity and Inclusion Officer, Shares Her Passion for a Brighter Future
finance.yahoo.com - August 25 at 5:17 PM
The Top 3 Healthcare Dividend Stocks to Buy and Hold (UNH)The Top 3 Healthcare Dividend Stocks to Buy and Hold (UNH)
marketbeat.com - August 18 at 5:47 PM
Diversification Can Smooth Returns And Mitigate Portfolio Risk (UNH)Diversification Can Smooth Returns And Mitigate Portfolio Risk (UNH)
marketbeat.com - July 20 at 8:41 PM
UnitedHealth Group For Healthy Dividend Growth PortfoliosUnitedHealth Group For Healthy Dividend Growth Portfolios
marketbeat.com - July 16 at 5:30 AM
The Top 3 Healthcare Stocks to Buy in JulyThe Top 3 Healthcare Stocks to Buy in July
marketbeat.com - July 7 at 5:10 AM
3 Stocks Leading The Dow Industrials In Price Gains This Year  (UNH)3 Stocks Leading The Dow Industrials In Price Gains This Year (UNH)
marketbeat.com - June 29 at 7:43 AM
3 High-Quality Dividend Payers About To Increase Their Payouts  (UNH)3 High-Quality Dividend Payers About To Increase Their Payouts (UNH)
marketbeat.com - April 20 at 8:28 PM
UnitedHealth Group Rockets To New High UnitedHealth Group Rockets To New High
marketbeat.com - April 15 at 3:28 PM

Latest Healthcare Stock Analyst Ratings

DateCompanyBrokerageAction
9/20/2021PfizerSVB Leerink
Boost Price Target
9/20/2021NovartisDeutsche Bank Aktiengesellschaft
Downgrade
9/14/2021PfizerSVB Leerink
Reiterated Rating
9/13/2021PfizerJPMorgan Chase & Co.
Boost Price Target
9/9/2021UnitedHealth GroupCowen
Initiated Coverage
9/7/2021Johnson & JohnsonMorgan Stanley
Downgrade
9/7/2021Merck & Co., Inc.Morgan Stanley
Downgrade
8/31/2021UnitedHealth GroupMorgan Stanley
Lower Price Target
7/30/2021Merck & Co., Inc.SVB Leerink
Boost Price Target
7/30/2021PfizerMizuho
Boost Price Target
7/29/2021Johnson & JohnsonSVB Leerink
Reiterated Rating
7/29/2021PfizerThe Goldman Sachs Group
Set Price Target
7/29/2021PfizerMorgan Stanley
Boost Price Target
7/29/2021PfizerRoyal Bank of Canada
Set Price Target
7/29/2021PfizerSVB Leerink
Boost Price Target
7/28/2021NovartisJPMorgan Chase & Co.
Reiterated Rating
7/27/2021Merck & Co., Inc.Truist Securities
Initiated Coverage
7/27/2021Merck & Co., Inc.Truist
Initiated Coverage
7/27/2021PfizerTruist
Initiated Coverage
7/22/2021NovartisDeutsche Bank Aktiengesellschaft
Downgrade
7/21/2021Johnson & JohnsonSVB Leerink
Reiterated Rating
7/16/2021UnitedHealth GroupStephens
Boost Price Target
7/16/2021UnitedHealth GroupTruist Securities
Boost Price Target
7/16/2021UnitedHealth GroupTruist
Boost Price Target
7/16/2021UnitedHealth GroupRaymond James
Boost Price Target
7/16/2021UnitedHealth GroupCredit Suisse Group
Boost Price Target
7/16/2021UnitedHealth GroupCitigroup
Boost Price Target
7/16/2021UnitedHealth GroupBarclays
Boost Price Target
7/15/2021UnitedHealth GroupOppenheimer
Reiterated Rating
7/13/2021UnitedHealth GroupDeutsche Bank Aktiengesellschaft
Boost Price Target
7/9/2021UnitedHealth GroupSeaport Res Ptn
Reiterated Rating
7/9/2021UnitedHealth GroupSeaport Global Securities
Initiated Coverage
6/17/2021PfizerRoyal Bank of Canada
Boost Price Target
6/15/2021PfizerBerenberg Bank
Reiterated Rating
6/9/2021Merck & Co., Inc.JPMorgan Chase & Co.
Lower Price Target
6/7/2021Johnson & JohnsonCredit Suisse Group
Set Price Target
6/7/2021Merck & Co., Inc.Truist Securities
Lower Price Target
6/3/2021Merck & Co., Inc.SVB Leerink
Lower Price Target
6/1/2021Johnson & JohnsonCredit Suisse Group
Set Price Target
6/1/2021UnitedHealth GroupBank of America
Boost Price Target
5/28/2021Johnson & JohnsonMorgan Stanley
Initiated Coverage
5/24/2021PfizerJPMorgan Chase & Co.
Set Price Target
5/24/2021PfizerThe Goldman Sachs Group
Set Price Target
5/24/2021UnitedHealth GroupWells Fargo & Company
Initiated Coverage
5/21/2021UnitedHealth GroupTruist Securities
Boost Price Target
5/20/2021Merck & Co., Inc.Argus
Reiterated Rating
5/18/2021UnitedHealth GroupWells Fargo & Company
Initiated Coverage
5/13/2021PfizerThe Goldman Sachs Group
Reiterated Rating
5/12/2021PfizerMizuho
Reiterated Rating
5/11/2021NovartisMorgan Stanley
Reiterated Rating
5/10/2021PfizerMorgan Stanley
Boost Price Target
5/7/2021UnitedHealth GroupMizuho
Boost Price Target
5/6/2021PfizerMizuho
Downgrade
5/5/2021PfizerSVB Leerink
Boost Price Target
5/5/2021PfizerJPMorgan Chase & Co.
Boost Price Target
5/5/2021PfizerBarclays
Boost Price Target
4/30/2021Merck & Co., Inc.SVB Leerink
Lower Price Target
4/28/2021NovartisJPMorgan Chase & Co.
Reiterated Rating
4/28/2021NovartisOddo Bhf
Upgrade
4/21/2021UnitedHealth GroupArgus
Upgrade
4/19/2021NovartisUBS Group
Reiterated Rating
4/16/2021UnitedHealth GroupStephens
Boost Price Target
4/16/2021UnitedHealth GroupCredit Suisse Group
Boost Price Target
4/16/2021UnitedHealth GroupMorgan Stanley
Boost Price Target
4/16/2021UnitedHealth GroupBMO Capital Markets
Boost Price Target
4/16/2021UnitedHealth GroupOppenheimer
Boost Price Target
4/16/2021UnitedHealth GroupDeutsche Bank Aktiengesellschaft
Boost Price Target
4/7/2021PfizerRoyal Bank of Canada
Initiated Coverage
4/6/2021PfizerThe Goldman Sachs Group
Set Price Target
3/31/2021PfizerThe Goldman Sachs Group
Set Price Target
3/26/2021PfizerSVB Leerink
Lower Price Target
3/23/2021PfizerBerenberg Bank
Reiterated Rating
3/23/2021NovartisSociete Generale
Reiterated Rating
3/22/2021NovartisSanford C. Bernstein
Initiated Coverage
3/16/2021NovartisArgus
Reiterated Rating
3/10/2021NovartisArgus
Downgrade
2/5/2021Merck & Co., Inc.Cantor Fitzgerald
Reiterated Rating
2/2/2021NovartisMorgan Stanley
Reiterated Rating
2/1/2021NovartisCowen
Downgrade
1/27/2021Johnson & JohnsonJPMorgan Chase & Co.
Boost Price Target
1/27/2021Johnson & JohnsonCredit Suisse Group
Boost Price Target
1/27/2021Johnson & JohnsonRaymond James
Boost Price Target
1/27/2021Johnson & JohnsonCowen
Boost Price Target
1/27/2021Johnson & JohnsonMorgan Stanley
Boost Price Target
1/27/2021Johnson & JohnsonSVB Leerink
Boost Price Target
1/27/2021Johnson & JohnsonWells Fargo & Company
Boost Price Target
1/26/2021Johnson & JohnsonCantor Fitzgerald
Boost Price Target
1/22/2021NovartisBarclays
Reiterated Rating
1/15/2021NovartisDeutsche Bank Aktiengesellschaft
Initiated Coverage
1/8/2021NovartisMorgan Stanley
Reiterated Rating
12/15/2020Johnson & JohnsonMorgan Stanley
Boost Price Target
12/6/2020Merck & Co., Inc.Mizuho
Reiterated Rating
12/3/2020NovartisArgus
Boost Price Target
11/25/2020NovartisUBS Group
Reiterated Rating
11/20/2020Johnson & JohnsonRaymond James
Reiterated Rating
11/10/2020Merck & Co., Inc.Sanford C. Bernstein
Reiterated Rating
11/10/2020NovartisJPMorgan Chase & Co.
Reiterated Rating
10/29/2020Merck & Co., Inc.SVB Leerink
Boost Price Target
10/23/2020Merck & Co., Inc.Truist
Initiated Coverage
10/16/2020Merck & Co., Inc.JPMorgan Chase & Co.
Boost Price Target
10/14/2020Johnson & JohnsonCredit Suisse Group
Boost Price Target
10/14/2020Johnson & JohnsonCantor Fitzgerald
Boost Price Target
10/13/2020Johnson & JohnsonCredit Suisse Group
Set Price Target
9/29/2020Merck & Co., Inc.Berenberg Bank
Initiated Coverage
9/29/2020NovartisBerenberg Bank
Initiated Coverage
9/23/2020NovartisOddo Bhf
Downgrade
9/22/2020Merck & Co., Inc.Mizuho
Reiterated Rating
9/10/2020NovartisUBS Group
Upgrade
9/4/2020Johnson & JohnsonCredit Suisse Group
Reiterated Rating
9/1/2020NovartisMorgan Stanley
Upgrade
8/25/2020Merck & Co., Inc.SVB Leerink
Boost Price Target
8/19/2020Johnson & JohnsonStifel Nicolaus
Downgrade
8/12/2020NovartisJPMorgan Chase & Co.
Reiterated Rating
8/4/2020Merck & Co., Inc.Royal Bank of Canada
Reiterated Rating
8/3/2020Johnson & JohnsonCantor Fitzgerald
Reiterated Rating
8/3/2020Merck & Co., Inc.The Goldman Sachs Group
Upgrade
7/31/2020Merck & Co., Inc.Mizuho
Reiterated Rating
7/28/2020NovartisMorgan Stanley
Reiterated Rating
7/20/2020Johnson & JohnsonBank of America
Reiterated Rating
7/20/2020Johnson & JohnsonIndependent Research
Upgrade
7/17/2020Johnson & JohnsonRaymond James
Boost Price Target
6/23/2020Merck & Co., Inc.Mizuho
Reiterated Rating
6/23/2020Merck & Co., Inc.Morgan Stanley
Reiterated Rating
6/12/2020Merck & Co., Inc.Wolfe Research
Downgrade
5/4/2020Merck & Co., Inc.Credit Suisse Group
Reiterated Rating
(Data available from 9/20/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.